Sanjay Shukla
President and CEO · aTYR PHARMA INC
- 2026
- Feb 5, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sanjay Shukla files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Schimmel - $50K in ATYR purchases and sales in the last 12 months
- Jill Marie Broadfoot - $2K in ATYR purchases and sales in the last 12 months
- Nancy Denyes - $1K in ATYR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sanjay Shukla?
Sanjay Shukla is a corporate insider, tracked as President and CEO of aTYR PHARMA INC (ATYR). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Sanjay Shukla last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 2 filings going back to 2026.
Has Sanjay Shukla been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($4K) across all tracked filings.
